Q32 BioQTTB
那斯達克 · USD
5.05
+0.13
(+2.64%)
收盤 04/11 03:59 (UTC+8)
盤後
5.17
+0.12
(+2.38%)
04/11 03:59 (UTC+8)
Q32 BioQTTB
5.05
+0.13
(+2.64%)
財務數據
損益表
- 0.02
- -
- -
- -
- -
- -
- -
- -
- -
- 0.54
- -42.00
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | |
營業收入淨額 | 53,737 | - | - | - | - | - | - | - | - | 1,859 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 53,737 | - | - | - | - | - | - | - | - | 1,859 |
營業費用 | 7,858 | 7,577 | 9,172 | 12,228 | 14,526 | 18,814 | - | - | 12,101 | 9,657 |
研發費用 | 3,315 | 3,555 | 5,162 | 7,124 | 10,545 | 14,346 | 13,411 | 9,841 | 1,513 | 7,463 |
推銷及管理費用 | 4,543 | 4,022 | 4,010 | 5,104 | 3,981 | 4,468 | 4,508 | 5,002 | 7,901 | 2,194 |
非經常性項目費用 | - | - | - | - | - | - | - | - | 2,687 | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 45,879 | -7,577 | -9,172 | -12,228 | -14,526 | -18,814 | -17,919 | -14,843 | -12,101 | -7,798 |
其他收入及費用 | 11,851 | 188 | -317 | 1,197 | 358 | 1,219 | 2,390 | 16,048 | 9,946 | -6,168 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | 57,730 | -7,389 | -9,489 | -11,031 | -14,168 | -17,595 | -15,529 | 1,205 | -2,155 | -13,966 |
所得稅 | - | - | - | - | 21 | - | - | - | - | 65 |
稅後純益 | 57,730 | -7,389 | -9,489 | -11,031 | -14,189 | -17,595 | -16,978 | 1,029 | -16,119 | -14,031 |
基本每股稅後盈餘(元) | 4.70 | -0.60 | -0.78 | -0.90 | -2.33 | -1.46 | -1.42 | 0.09 | - | -1.18 |
稀釋每股稅後盈餘(元) | 4.71 | -0.61 | -0.78 | -0.90 | -0.98 | -1.16 | 1.89 | -6.33 | -4.86 | -40.29 |
基本平均股數(千股) | 12568.00 | 12240.00 | 12197.00 | 12197.00 | 1314.00 | 12076.00 | 11964.00 | 11929.00 | - | 11929.00 |
稀釋平均股數(千股) | 12625.00 | 12240.00 | 12197.00 | 12197.00 | 2661.00 | 12076.00 | 11964.00 | 11929.00 | - | 11929.00 |
還原基本每股稅後盈餘(元) | 4.70 | -0.60 | -0.78 | -0.90 | -2.33 | -1.46 | -1.42 | 0.09 | - | -1.18 |
還原稀釋每股稅後盈餘(元) | 4.71 | -0.61 | -0.78 | -0.90 | -0.98 | -1.16 | 1.89 | -6.33 | -4.86 | -40.29 |
還原基本平均股數(千股) | 12,568 | 12,240 | 12,197 | 12,197 | 1,314 | 12,076 | 11,964 | 11,929 | - | 11,929 |
還原稀釋平均股數(千股) | 12,625 | 12,240 | 12,197 | 12,197 | 2,661 | 12,076 | 11,964 | 11,929 | - | 11,929 |
EBITDA(千元) | 57,857 | -7,252 | -9,349 | -10,864 | -13,999 | -17,437 | -16,997 | 1,181 | -16,788 | -13,835 |